Search Results - "Ferrer‐Marín, F."

Evaluation of two-step haemoglobin screening with HemoCue for blood donor qualification in mobile collection sites by Gómez-Simón, A., Plaza, E. M., Torregrosa, J. M., Ferrer-Marín, F., Sánchez-Guiu, I., Vicente, V., Lozano, M. L., Rivera, J.

“…Background and Objectives Inaccuracy of fingerstick haemoglobin compromises donor's health and losses blood donations. We evaluated the benefit of double…”
Get full text

P1001: DNMT3A/TET2/ASXL1 MUTATIONS DETERMINE THROMBOTIC RISK IN POLYCYTHAEMIA VERA by Segura Diaz, A., Stuckey, R., Florido Ortega, Y., Sobas, M., Álvarez Larrán, A., Ferrer‐Marín, F., Pérez Encinas, M., Carreño, G., Fox, M., Tazón Vega, B., Cuevas, B., López Rodriguez, J., Farías Sánchez, N., Bilbao Sieyro, C., Gómez Casares, M.

Get full text

P997: PROTEOMIC ANALYSIS ON PLATELETS OF ESSENTIAL THROMBOCYTHEMIA PATIENTS UNDERSCORES THE ROLE OF MITOCHONDRIA IN JAK2 V617F PLATELET REACTIVITY AND FUNCTION by Guerrero‐Carreño, X., Smits, S., Esteban Lasso, A., Escudero García, J. A., Samiotaki, M., Alvarez‐Larrán, A., Angona, A., Sáen Marín, A. J., García Gutiérrez, V., Dekkers, D., Demmers, J., Benavente Cuesta, C. M., Ferrer‐Marín, F., Hernández‐Boluda, J. C., Iborra, F. J., De Cuyper, I. M., Vandenberghe, P., Papadopoulos, P.

Get full text

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk by Ferrer-Marín, F., Arroyo, A. B., Bellosillo, B., Cuenca, E. J., Zamora, L., Hernández-Rivas, J. M., Hernández-Boluda, J. C., Fernandez-Rodriguez, C., Luño, E., García Hernandez, C., Kerguelen, A., Fiallo-Suárez, D. V., Gómez-Casares, M. T., Ayala, R., Vélez, P., Boqué, C., García-Gutierrez, V., Arrizabalaga, B., Estrada, N., Cifuentes, R., Arcas, I., de los Reyes-García, A. M., Besses, C., Vicente, V., Alvarez-Larrán, A., Teruel-Montoya, R., González-Conejero, R., Martínez, C.

“…Myelofibrosis (MF) occurs as part of the natural history of polycythemia vera (PV) and essential thrombocythemia (ET), and remarkably shortens survival…”
Get full text

Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis by Hernández-Boluda, J-C, Pereira, A, Correa, J-G, Alvarez-Larrán, A, Ferrer-Marín, F, Raya, J-M, Martínez-López, J, Pérez-Encinas, M, Estrada, N, Velez, P, Fox, M-L, García-Gutiérrez, V, Payer, A, Kerguelen, A, Cuevas, B, Durán, M-A, Ramírez, M-J, Gómez-Casares, M-T, Mata-Vázquez, M-I, Mora, E, Martínez-Valverde, C, Gómez, M, Cervantes, F

Get full text

Effects of in vitro adult platelet transfusions on neonatal hemostasis by FERRER‐MARIN, F., CHAVDA, C., LAMPA, M., MICHELSON, A. D., FRELINGER, A. L., SOLA‐VISNER, M.

“…Background: Thrombocytopenia is frequent among neonates, and 20–25% of affected infants are treated with platelet transfusions. These are frequently given for…”
Get full text

MiR‐9 contributes to the developmental differences in CXCR‐4 expression in human megakaryocytes by Ferrer‐Marin, F., Gutti, R., Liu, Z.‐J., Sola‐Visner, M.

Get full text

DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia by Hurtado, A.M, Luengo-Gil, G, Chen-Liang, T.H, Palomo, L, Lumbreras, E, Przychodzen, B, Amigo, M.L, Díez-Campelo, M, Zamora, L, Ortuño, F, Vicente, V, Maciejewski, J, del Cañizo, C, Solé, F, Ferrer-Marín, F, Jerez, A

Get full text

P1032: REAL‐LIFE VALIDATION OF MIPSS70: A RETROSPECTIVE MULTICENTER AND NGS ANALYSIS FROM THE GEMFIN DATABASE by Hernández‐Sánchez, A., Villaverde‐Ramiro, Á., Álvarez‐Larrán, A., Arellano‐Rodrigo, E., Pérez Encinas, M., Ferrer Marín, F., Such, E., Carreño Gómez‐Tarragona, G., Heras Rodríguez, N., Durán Pastor, M. A., Mata Vázquez, M. I., Fox, L., Raya Sánchez, J. M., Magro Mazo, E., Gómez Casares, M. T., Ramírez Sánchez, M. J., Xicoy Cirici, B., Ramírez Páyer, Á., Fernández Llavador, M. J., Martín López, A. Á., Mosquera Orgueira, A., Martínez Elicegui, J., Garrote, M., Bellosillo, B., González, T., Hernández‐Rivas, J., Hernández Boluda, J. C.

Get full text

C0405: Role of Syntaxin-11 in Granule Release of Neonatal Platelets by Caparrós-Pérez, E, Teruel-Montoya, R, Delgado, J.L, Torregrosa, J.M, Navarro, F, Montoya, N, Rivera, J, Llanos, M.C, Vicente, V, Martínez, C, Ferrer-Marín, F

Get full text

C0403: Gene Expression Differences Between Neonatal and Adult Platelets: New Potential Modulators of Human Platelet Reactivity by Caparrós-Pérez, E, Teruel-Montoya, R, Torregrosa, J.M, Delgado, J.L, Llanos, M.C, Rivera, J, González-Conejero, R, Vicente, V, Martínez, C, Ferrer-Marín, F

Get full text

The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms by Soler, G., Bernal-Vicente, A., Antón, A. I., Torregrosa, J. M., Caparrós-Pérez, E., Sánchez-Serrano, I., Martínez-Pérez, A., Sánchez-Vega, B., Vicente, V., Ferrer-Marin, F.

“…Somatic mutations in the CALR gene were recently discovered in a substantial proportion of Philadelphia-negative chronic myeloproliferative neoplasm (cMPN)…”
Get full text

Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care? by Sallmon, H, Gutti, R K, Ferrer-Marin, F, Liu, Z-J, Sola-Visner, M C

“…The Food and Drug Administration recently approved two novel thrombopoiesis-stimulating agents, Romiplostim (AMG-531, Nplate) and Eltrombopag (Promacta), for…”
Get full text

Performance of the myelofibrosis secondary to PV and ET-prognostic model by Raya, J-M, Martínez-López, J, Cuevas, B, Gómez-Casares, M-T, Pereira, A, Estrada, N, Kerguelen, A, Ferrer-Marín, F, Payer, A, Cervantes, F, Hernández-Boluda, J-C, Velez, P, Fox, M-L, Mora, E, Alvarez-Larrán, A, Durán, M-A, Mata-Vázquez, M-I, Pérez-Encinas, M, Gómez, M, Correa, J-G, Ramírez, M-J, Martínez-Valverde, C, García-Gutiérrez, V

Get full text

An atypical IgM class platelet cold agglutinin induces GPVI-dependent aggregation of human platelets by Sánchez Guiu, I M, Martínez-Martinez, I, Martínez, C, Navarro-Fernandez, J, García-Candel, F, Ferrer-Marín, F, Vicente, V, Watson, S P, Andrews, R K, Gardiner, E E, Lozano, M L, Rivera, J

“…Platelet cold agglutinins (PCA) cause pseudothrombocytopenia, spurious thrombocytopenia due to ex vivo platelet clumping, complicating clinical diagnosis, but…”
Get more information

163 - DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia by Hurtado, A.M., Luengo-Gil, G., Chen-Liang, T.H., Palomo, L., Lumbreras, E., Przychodzen, B., Amigo, M.L., Díez-Campelo, M., Zamora, L., Ortuño, F., Vicente, V., Maciejewski, J., del Cañizo, C., Solé, F., Ferrer-Marín, F., Jerez, A.

Get full text

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation by Alvarez-Larrán, Alberto, Pereira, Arturo, Guglielmelli, Paola, Hernández-Boluda, Juan Carlos, Arellano-Rodrigo, Eduardo, Ferrer-Marín, Francisca, Samah, Alimam, Griesshammer, Martin, Kerguelen, Ana, Andreasson, Bjorn, Burgaleta, Carmen, Schwarz, Jiri, García-Gutiérrez, Valentín, Ayala, Rosa, Barba, Pere, Gómez-Casares, María Teresa, Paoli, Chiara, Drexler, Beatrice, Zweegman, Sonja, McMullin, Mary F, Samuelsson, Jan, Harrison, Claire, Cervantes, Francisco, Vannucchi, Alessandro M, Besses, Carlos

“…The role of antiplatelet therapy as primary prophylaxis of thrombosis in low-risk essential thrombocythemia has not been studied in randomized clinical trials…”
Get full text

Linfoma pulmonar primario de bajo grado no BALT by Ferrer Marín, F., Avilés Inglés, M. J.

Get full text

Correction of anaemia on dialysis: did we forget physiology? by HERTIG, Alexandre, FERRER-MARIN, Francisca

Get full text

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis by Hernández-Boluda, Juan-Carlos, Pereira, Arturo, Gómez, Montse, Boqué, Concepción, Ferrer-Marín, Francisca, Raya, José-María, García-Gutiérrez, Valentín, Kerguelen, Ana, Xicoy, Blanca, Barba, Pere, Martínez, Jesús, Luño, Elisa, Alvarez-Larrán, Alberto, Martínez-López, Joaquín, Arbelo, Elisa, Besses, Carles

Get full text